health
1 min read
Breast Cancer Drug Enhertu Approved for Use in England's NHS
09/25/2026 · Rhode Island edition
London, England — The National Health Service (NHS) in England has approved Enhertu, a medication for breast cancer patients.
Patients taking Enhertu have experienced an average of seven additional months of life, according to clinical data. The drug has been accessible to patients in Scotland for over two years.
This approval integrates Enhertu into England's NHS treatment protocols, expanding options for eligible breast cancer patients.
Related Topics
Editorial Transparency
AI-Generated · Written by National DeskArticle Ratings
Factual
0.0
Likeable
0.0
Bias
0.0
Objective
0.0
How do you feel about this story?
NA
National Desk
Trust 3.176467 articles8,284,930 views75% fact accuracy
View ProfileSign in to follow this author from their profile.
Discussion (0)
Join the Conversation
No comments yet. Be the first to comment!